Literature DB >> 12493346

Pathophysiology: the varieties of bladder overactivity.

Jacek L Mostwin1.   

Abstract

Overactive bladder (OAB) is the most common term currently used in clinical medicine to describe a complex of lower urinary tract symptoms (LUTS) with or without incontinence. The symptoms usually include urgency, frequency, nocturia, troublesome or incomplete emptying, and, occasionally, pain. Causes of bladder overactivity include neurologic illness or injury, bladder outlet obstruction, urethral weakness, detrusor hyperactivity and impaired contractility in elderly patients, emergence of new voiding reflexes, and so-called idiopathic bladder overactivity. Most clinicians agree that effective treatment for OAB symptoms should be guided by a basic assessment of patients for these contributing factors. However, it is not at all certain that outcomes are significantly improved by diagnostic precision. This is in part because of the ubiquity of LUTS in the setting of the various common lower urinary tract disorders: stress incontinence, outlet obstruction, and neurologic illness or injury. The ubiquity of LUTS would imply that they are caused by common mechanisms and, theoretically at least, would be amenable to a single form of effective therapy. Conversely, the limited kinds and number of LUTS and the limited representation of lower urinary tract structures in the central nervous system may mean that several different causes produce similar symptoms, but these are not amenable to a single form of effective therapy. Future research directions should keep each possible explanation in mind as new knowledge about lower urinary tract function and possible intervention continues to emerge.

Entities:  

Mesh:

Year:  2002        PMID: 12493346     DOI: 10.1016/s0090-4295(02)01788-0

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  11 in total

Review 1.  Pharmacological management of women with mixed urinary incontinence.

Authors:  Hashim Hashim; Paul Abrams
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder.

Authors:  Rodney U Anderson; Scott MacDiarmid; Sherron Kell; James H Barada; Scott Serels; Roger P Goldberg
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-05-03

3.  Cerebral control of the bladder in normal and urge-incontinent women.

Authors:  Derek Griffiths; Stasa D Tadic; Werner Schaefer; Neil M Resnick
Journal:  Neuroimage       Date:  2007-05-18       Impact factor: 6.556

4.  A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder.

Authors:  Ernesto Callegari; Bimal Malhotra; Peter J Bungay; Rob Webster; Katherine S Fenner; Sarah Kempshall; Jennifer L LaPerle; Martin C Michel; Gary G Kay
Journal:  Br J Clin Pharmacol       Date:  2011-08       Impact factor: 4.335

5.  Risk factors for renal scarring in children and adolescents with lower urinary tract dysfunction.

Authors:  Cristiane R Leonardo; Maria Francisca T Filgueiras; Mônica M Vasconcelos; Roberta Vasconcelos; Viviane P Marino; Cleidismar Pires; Ana Cristina Pereira; Fernanda Reis; Eduardo A Oliveira; Eleonora M Lima
Journal:  Pediatr Nephrol       Date:  2007-09-14       Impact factor: 3.714

6.  The electrovesicogram in the overactive bladder: role in determining pathogenesis and diagnostic significance.

Authors:  Ahmed Shafik; Olfat El-Sibai; Ali A Shafik; Ismail Ahmed
Journal:  Urol Res       Date:  2004-03-26

7.  The Impact of Increased Bladder Blood Flow on Storage Symptoms after Holmium Laser Enucleation of the Prostate.

Authors:  Keisuke Saito; Shin-ichi Hisasue; Hisamitsu Ide; Hiroaki Aoki; Satoru Muto; Raizo Yamaguchi; Akira Tsujimura; Shigeo Horie
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

8.  Intravesical Sodium Chondroitin Sulphate to Treat Overactive Bladder: Preliminary Result.

Authors:  Lokman Irkilata; Mustafa Aydin; Hasan Riza Aydin; Hüseyin Cihan Demirel; Mustafa Kadihasanoglu; Mustafa Kemal Atilla
Journal:  Int Neurourol J       Date:  2015-06-29       Impact factor: 2.835

9.  Prevalence, evaluation and management of overactive bladder in primary care.

Authors:  Wellman W Cheung; Nadia H Khan; Karmina K Choi; Martin H Bluth; Miriam T Vincent
Journal:  BMC Fam Pract       Date:  2009-01-23       Impact factor: 2.497

10.  Characterization of overactive bladder in women in a primary care setting.

Authors:  Wellman W Cheung; Dorota Borawski; Ovadia Abulafia; Miriam T Vincent; Miriam Harel; Martin H Bluth
Journal:  Open Access J Urol       Date:  2011-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.